A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease
Clinical trial NCT06973668 · RECRUITING
Trial details
- NCT number
- NCT06973668
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-22
- Primary completion
- 2028-01-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.